Sibuzone 20 - Alphazone Pharmaceuticals

Sibutramine hydrochloride, once marketed under the brand name Meridia®, is a serotonin and norepinephrine reuptake inhibitor initially developed for obesity management. It functions by suppressing appetite and increasing metabolic rate, aiding in weight loss. Clinical studies demonstrated significant weight reduction in obese patients over 24 weeks of treatment. Despite its efficacy, sibutramine was withdrawn from the market in 2010 due to increased cardiovascular risks, including elevated blood pressure and heart rate.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Sibuzone 20 by Alphazone Pharmaceuticals, consult with your doctor or healthcare professional.